Aclaris Therapeutics
Kevin Balthaser, CPA, MBA, has extensive experience in finance and accounting. Currently serving as the Chief Financial Officer and Vice President of Finance at Aclaris Therapeutics, Inc., Kevin has held various leadership roles including Sr. Director of Finance and Corporate Controller. Prior to their current role, Kevin worked at Lannett Company as the Director of Strategic Initiatives and Manager of Financial Reporting/Finance. Kevin started their career at PricewaterhouseCoopers as an Experienced Associate. Kevin holds an MBA from Villanova University and a B.S. in Finance from Penn State University.
This person is not in any teams
This person is not in any offices
Aclaris Therapeutics
Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates to address the needs of patients with immuno-inflammatory diseases who lack satisfactory treatment options.